| 000 | 01564 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513075546.0 | ||
| 264 | 0 | _c19931029 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00070a015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaines, R A | |
| 245 | 0 | 0 |
_a(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cSep 1993 |
||
| 300 |
_a2703-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemical synthesis |
| 650 | 0 | 4 |
_aBenzoates _xchemical synthesis |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aLeukotriene B4 _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 |
_aReceptors, Leukotriene B4 _xantagonists & inhibitors |
| 700 | 1 | _aChambers, P A | |
| 700 | 1 | _aPendrak, I | |
| 700 | 1 | _aJakas, D R | |
| 700 | 1 | _aSarau, H M | |
| 700 | 1 | _aFoley, J J | |
| 700 | 1 | _aSchmidt, D B | |
| 700 | 1 | _aGriswold, D E | |
| 700 | 1 | _aMartin, L D | |
| 700 | 1 | _aTzimas, M N | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 36 _gno. 18 _gp. 2703-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00070a015 _zAvailable from publisher's website |
| 999 |
_c8410256 _d8410256 |
||